1. Home
  2. AERT vs LSTA Comparison

AERT vs LSTA Comparison

Compare AERT & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$6.35

Market Cap

34.9M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.45

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
LSTA
Founded
2012
1980
Country
Singapore
United States
Employees
1400
N/A
Industry
Professional Services
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
28.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
AERT
LSTA
Price
$6.35
$3.45
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
406.4K
96.3K
Earning Date
02-09-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.26
$1.81
52 Week High
$6.90
$5.07

Technical Indicators

Market Signals
Indicator
AERT
LSTA
Relative Strength Index (RSI) 89.16 49.77
Support Level $0.45 $3.06
Resistance Level N/A $3.67
Average True Range (ATR) 0.32 0.18
MACD 0.60 0.03
Stochastic Oscillator 90.56 35.11

Price Performance

Historical Comparison
AERT
LSTA

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: